2-(4-METHYLPHENYL)IMIDAZO[1,2-A]PYRIMIDINE
- $220 - $4320
- Product name: 2-(4-METHYLPHENYL)IMIDAZO[1,2-A]PYRIMIDINE
- CAS: 56921-83-6
- MF: C13H11N3
- MW: 209.25
- EINECS:
- MDL Number:MFCD02681314
- Synonyms:2-P-TOLYL-IMIDAZO[1,2-A]PYRIMIDINE;2-(4-METHYLPHENYL)IMIDAZO[1,2-A]PYRIMIDINE;Imidazo[1,2-a]pyrimidine, 2-(4-methylphenyl)-
4 prices
Selected condition:
Brand
- AccelPharmtech
- American Custom Chemicals Corporation
- TRC
Package
- 5MG
- 500mg
- 5G
- 25G
- ManufacturerAccelPharmtech
- Product numberA6526
- Product description2-(4-methylphenyl)-Imidazo[1,2-a]pyrimidine 97.00%
- Packaging5G
- Price$2330
- Updated2021-12-16
- Buy
- ManufacturerAccelPharmtech
- Product numberA6526
- Product description2-(4-methylphenyl)-Imidazo[1,2-a]pyrimidine 97.00%
- Packaging25G
- Price$4320
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0073981
- Product description2-(4-METHYLPHENYL)IMIDAZO[1,2-A]PYRIMIDINE 95.00%
- Packaging5MG
- Price$495.88
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM224415
- Product description2-(4-Methylphenyl)imidazo[1,2-A]pyrimidine
- Packaging500mg
- Price$220
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AccelPharmtech | A6526 | 2-(4-methylphenyl)-Imidazo[1,2-a]pyrimidine 97.00% | 5G | $2330 | 2021-12-16 | Buy |
AccelPharmtech | A6526 | 2-(4-methylphenyl)-Imidazo[1,2-a]pyrimidine 97.00% | 25G | $4320 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0073981 | 2-(4-METHYLPHENYL)IMIDAZO[1,2-A]PYRIMIDINE 95.00% | 5MG | $495.88 | 2021-12-16 | Buy |
TRC | M224415 | 2-(4-Methylphenyl)imidazo[1,2-A]pyrimidine | 500mg | $220 | 2021-12-16 | Buy |
Properties
Melting point :231 °C
Density :1.19±0.1 g/cm3(Predicted)
pka :4.77±0.30(Predicted)
Density :1.19±0.1 g/cm3(Predicted)
pka :4.77±0.30(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|